Man Group
SPPI

Man Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Man Group’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-34,208
Closed -$15K – 2319
2022
Q3 		$15K Buy
+34,208
New +$33.6K ﹤0.01% 1949
2022
Q2 		– Hold
0
– – – 2006
2020
Q2 		– Sell
-26,172
Closed -$61K – 1863
2020
Q1 		$61K Buy
+26,172
New +$71.6K ﹤0.01% 1543
2019
Q1 		– Sell
-13,300
Closed -$116K – 2101
2018
Q4 		$116K Sell
13,300
-174,371
-93% -$2.22M ﹤0.01% 1845
2018
Q3 		$3.15M Buy
+187,671
New +$4.06M 0.01% 1223
2018
Q2 		– Sell
-97,068
Closed -$1.56M – 2264
2018
Q1 		$1.56M Buy
+97,068
New +$1.92M 0.01% 1368

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Man Group's SPPI Position: Q4 2022 in Review

Man Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2022, closing a stake of 34,208 shares — an estimated $15K sold.

Man Group first reported a position in SPPI in Q1 2018 and held it in 5 quarters. The position peaked at $3.15M in Q3 2018. 70 funds tracked by Wall St. Rank hold SPPI as of Q4 2022.

  • Man Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2022 after selling out during the quarter.
  • Man Group sold 34,208 Spectrum Pharmaceuticals Inc shares in Q4 2022, an estimated $15K.
  • Man Group first reported a position in Spectrum Pharmaceuticals Inc in Q1 2018 and held it in 5 quarters.
  • Man Group's Spectrum Pharmaceuticals Inc position peaked at $3.15M in Q3 2018.
  • 70 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2022.

Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.